There was a significant difference between both cohorts for the following characteristics: age, tumor size, hormonal receptor (HR) status, nodal status, grade, lympho-vascular invasion, and local recurrences with a population showing more unfavorable characteristics in the IPC cohort 2. This evidence concerns the gene NR4A1 and neoplasm.